by Rhoda Wilson, Expose News:

In 2022, an outbreak of mpox (formerly known as monkeypox) garnered global attention, leading to a public health emergency declaration by the WHO.

In 2023, a new variant of the virus emerged, resulting in over 21,000 reported cases by August 2024. WHO declared the epidemic a public health emergency of international concern in August 2024.

The Project BioShield Act of 2004 aimed to defend against bioterrorism by accelerating the research and availability of medical countermeasures. This led to the development of Jynneos, the first approved monkeypox vaccine developed by Bavarian Nordic.